Aging
Navigate
Back to articleFigure 2(2 of 7)
100%
Figure 2
Figure 2.Survival analysis of ZBTB7C in different tumors. OS and Cox regression analyses of (A, E) colon adenocarcinoma (COAD), (B, F) lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), (C, G) esophageal carcinoma (ESCA) and (D, H) mesothelioma (MESO). OS, overall survival.
Figure 2 — The prognostic and immunological effects of ZBTB7C across cancers: friend or foe? | Aging